載入...
Discovery and Development of Toll-Like Receptor 4 (TLR4) Antagonists: A New Paradigm for Treating Sepsis and Other Diseases
Sepsis remains the most common cause of death in intensive care units in the USA, with a current estimate of at least 750,000 cases per year, and 215,000 deaths annually. Despite extensive research still we do not quite understand the cellular and molecular mechanisms that are involved in triggering...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer US
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2469272/ https://ncbi.nlm.nih.gov/pubmed/18493843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-008-9571-x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|